The global pandemic produced a slow-burning mass trauma event with huge implications for today’s employers.

In this case study, learn how a large pharmaceutical company partnered with meQ to embed resilience in its culture — and measurably improve the mental wellbeing of its people.


GET THE
CASE STUDY

WHAT HAPPENS WHEN LEADERS COMMIT TO
WORKFORCE RESILIENCE:

74%

improvement in stress management

40%

improvement in work-life balance

Company leadership was committed to get to the root of employee mental health risks. With meQ, they did — and the risks dropped.